Ultrasound Imaging | NYU Langone Health
NYU Langone provides abdominal, pelvic, and musculoskeletal ultrasound services to adults and children.
Female Pelvic Ultrasound
At NYU Langone, our specialists use the latest ultrasound technology to diagnose conditions in the female pelvis.
Obstetric–Gynecologic Ultrasound
At NYU Langone, our specialists provide a full range of obstetric and gynecologic ultrasound services.
A Phase 3 randomized open-label multicenter controlled study to evaluate the efficacy and safety of zanidatamab in combination with physician s choice chemotherapy compared to trastuzumab in combination with physician s choice chemotherapy for the treatment of participants with metastatic HER2-positive breast cancer who have progressed on or are intolerant to previous trastuzumab deruxtecan treatment
This study tests a new treatment called zanidatamab against a standard treatment called trastuzumab. Both treatments will be given with chemotherapy chosen by the doctor for patients with metastatic HER2-positive breast cancer who have not done well on or cannot tolerate a previous treatment called T-DXd. To join the study, patients need to have had at least two lines of HER2-directed therapies before. Patients will be checked for HER2-positive status before being enrolled, and randomization will happen once they meet all the study criteria. Patients will be assigned randomly to one of the two treatments, with groups based on their past treatments and where they live. They will receive their treatment in 21-day cycles until their disease gets worse, they decide to leave the study, or other reasons to stop occur. The study will keep a close watch on how effective the treatments are, with patients getting regular scans to check their health.
Ultrasound Unit—OB/GYN | NYU Langone Health
Doctors at NYU Langone’s Ultrasound Unit—OB/GYN provide fetal monitoring during pregnancy.
Ultrasound Unit—OB/GYN Doctors | NYU Langone Health
Find a doctor at the Ultrasound Unit—OB/GYN at NYU Langone.
Laser Therapy & Dermabrasion for Aging Skin | NYU Langone Health
NYU Langone skin specialists use laser therapies and dermabrasion to smooth wrinkles and lines associated with aging skin.
Updated musculoskeletal ultrasound applications and techniques
The aim of this study is to prospectively acquire clinical ultrasound data utilizing newer versions of preexisting US applications performed with a Siemens Acuson Sequoia system, updated acquisition protocols, sequences, and transducers. This will be performed as part out the routine standard of clinical care.
Ultrasound Channel Data Analysis Using Advanced Analytics and Deep Learning
Through the collection and analysis of the ultrasound channel data using advanced analytics and deep learning will provide new information previously unavailable that may improve the sensitivity and specificity of ultrasound in HCC detection and in the detection/quantification of liver fat and iron and may also improve diagnostic efficacy of ultrasound in the detection of HCC and assessment of chronic liver diseases through the use of channel data. Once the utility of channel data is determined in the setting of liver disease, its applications may potentially be applied to other organ systems.
A Phase 1/2 Study Evaluating the Safety and Efficacy of Amivantamab and Olomorasib Combination Therapy in Metastatic NSCLC KaRAnaSa (ISA-4)
This is a study in which patients have a specific change in their cancer cells called a KRAS G12C mutation, which means one tiny part of a gene (KRAS) has been changed in a way that may cause the cancer to grow. In this study, two medicines, Amivantamab and Olomorasib, are used together to treat this type of lung cancer (KRAS G12C-mutated metastatic NSCLC). Amivantamab is a special type of antibody that blocks two cancer related proteins (EGFR and MET) to stop cancer cell signaling. Olomorasib is an experimental medicine that blocks the KRAS G12C protein in cancer cells. This study consists of two parts: part one (combination dose selection) and part two (expansion). In Part one of the study, patients will be given the two medicines together to find the safest and most effective dose. Part two will see how well the two medicines work at the chosen dose to fight the cancer and slow down or prevent the growth of tumors. All patients will have frequent medical check ups and blood samples taken to see how their bodies are handling the study medicine. The study team will have special scans done for all patients to see how the cancer isresponding to the study medicines. The study team will be monitoring the patients for potential side effects and safety concerns.